Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Arthritis & Rheumatology (Hoboken, N.J.)|March 29, 2019
Enhanced Programmed Death 1 and Diminished Programmed Death Ligand 1 Up-Regulation Capacity of Post-Activated Lupus B CellsAna-Luisa Stefanski, Annika Wiedemann, Karin Reiter, et al.
Journal of Cell Communication and Signaling|April 30, 2016
Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptorSimon Lumb, Sarah J Fleischer, Annika Wiedemann, et al.
Rheumatology (Oxford, England)|May 2, 2020
Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibilityArman Aue, Franziska Szelinski, Sarah Y Weißenberg, et al.
Current Opinion in Rheumatology|December 13, 2018
Postactivated B cells in systemic lupus erythematosus: update on translational aspects and therapeutic considerationsEva Schrezenmeier, Sarah Y Weißenberg, Ana-Luisa Stefanski, et al.
Frontiers in Immunology|February 12, 2019
Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus NephritisMariele Gatto, Annika Wiedemann, Nadja Nomovi, et al.
Frontiers in Immunology|October 13, 2025
Soluble checkpoint molecules as predictive biomarker for disease activity and long-term outcome in SLELéa-Sophie Dreveton, Jakob Joachim Spencker, Hector Rincon-Arevalo, et al.
Frontiers in Immunology|July 25, 2024
Differential response of IgM and IgG memory B cell populations to CD40L: insights of T cell - memory B cell interactionsHector Rincon-Arevalo, Ana-Luisa Stefanski, Tuan Anh Le, et al.
Pageof 3